Published in J Histochem Cytochem on September 01, 1970
Capillary supply of the quadriceps femoris muscle of man: adaptive response to exercise. J Physiol (1977) 2.65
Maximum velocity of shortening in relation to myosin isoform composition in single fibres from human skeletal muscles. J Physiol (1993) 2.52
Force-velocity relations and myosin heavy chain isoform compositions of skinned fibres from rat skeletal muscle. J Physiol (1991) 2.25
Retracted Exercise induces interleukin-8 expression in human skeletal muscle. J Physiol (2004) 2.09
Early-phase muscular adaptations in response to slow-speed versus traditional resistance-training regimens. Eur J Appl Physiol (2012) 2.02
Rapid determination of myosin heavy chain expression in rat, mouse, and human skeletal muscle using multicolor immunofluorescence analysis. PLoS One (2012) 1.98
Skeletal muscle fiber type: influence on contractile and metabolic properties. PLoS Biol (2004) 1.93
A mechanism for increased contractile strength of human pennate muscle in response to strength training: changes in muscle architecture. J Physiol (2001) 1.89
Timing of postexercise protein intake is important for muscle hypertrophy with resistance training in elderly humans. J Physiol (2001) 1.69
Skeletal muscle substrate utilization during submaximal exercise in man: effect of endurance training. J Physiol (1993) 1.61
Resistance exercise-induced increase in muscle mass correlates with p70S6 kinase phosphorylation in human subjects. Eur J Appl Physiol (2007) 1.61
Exceptional evolutionary divergence of human muscle and brain metabolomes parallels human cognitive and physical uniqueness. PLoS Biol (2014) 1.56
Effects of endurance training on muscle fibre ATP-ase activity, capillary supply and mitochondrial content in man. J Physiol (1979) 1.55
Supplementation with vitamins C and E inhibits the release of interleukin-6 from contracting human skeletal muscle. J Physiol (2004) 1.37
Higher skeletal muscle alpha2AMPK activation and lower energy charge and fat oxidation in men than in women during submaximal exercise. J Physiol (2006) 1.34
Biochemical adaptation in the skeletal muscle of rats depleted of creatine with the substrate analogue beta-guanidinopropionic acid. Biochem J (1985) 1.25
Succinate dehydrogenase activity in fibres classified by myosin ATPase in three hind limb muscles of rat. J Physiol (1981) 1.25
Elevated muscle glycogen and anaerobic energy production during exhaustive exercise in man. J Physiol (1992) 1.25
Lactate and H+ effluxes from human skeletal muscles during intense, dynamic exercise. J Physiol (1993) 1.20
The multiplicity of combinations of myosin light chains and heavy chains in histochemically typed single fibres. Rabbit soleus muscle. Biochem J (1987) 1.20
Incisional herniation induces decreased abdominal wall compliance via oblique muscle atrophy and fibrosis. Ann Surg (2007) 1.19
Changes in muscle strength, muscle fibre size and myofibrillar gene expression after immobilization and retraining in humans. J Physiol (2000) 1.18
Neuromuscular adaptations during concurrent strength and endurance training versus strength training. Eur J Appl Physiol (2002) 1.16
Oral creatine supplementation facilitates the rehabilitation of disuse atrophy and alters the expression of muscle myogenic factors in humans. J Physiol (2001) 1.16
Myosin heavy chains IIa and IId are functionally distinct in the mouse. J Cell Biol (1998) 1.14
The slow component of oxygen uptake during intense, sub-maximal exercise in man is associated with additional fibre recruitment. Pflugers Arch (2004) 1.14
No difference in the skeletal muscle angiogenic response to aerobic exercise training between young and aged men. J Physiol (2007) 1.14
Myosin heavy chain isoform composition and Ca(2+) transients in fibres from enzymatically dissociated murine soleus and extensor digitorum longus muscles. J Physiol (2009) 1.13
Fibre types, calcium-sequestering proteins and metabolic enzymes in denervated and chronically stimulated muscles of the rat. J Physiol (1988) 1.11
Intense interval training enhances human skeletal muscle oxygen uptake in the initial phase of dynamic exercise at high but not at low intensities. J Physiol (2004) 1.10
Gene expression centroids that link with low intrinsic aerobic exercise capacity and complex disease risk. FASEB J (2010) 1.09
Elevated levels of IL-18 in plasma and skeletal muscle in chronic obstructive pulmonary disease. Lung (2007) 1.09
Interaction of training and diet on metabolism and endurance during exercise in man. J Physiol (1996) 1.09
Human skeletal muscle mitochondrial metabolism in youth and senescence: no signs of functional changes in ATP formation and mitochondrial oxidative capacity. Pflugers Arch (2003) 1.07
Fat utilization during exercise: adaptation to a fat-rich diet increases utilization of plasma fatty acids and very low density lipoprotein-triacylglycerol in humans. J Physiol (2001) 1.06
Reduced skeletal muscle capillarization and glucose intolerance. Microcirculation (2009) 1.05
Postnatal growth and differentiation of muscle fibres in the mouse. I. A histochemical and morphometrical investigation of normal muscle. J Anat (1983) 1.05
Contractile and electromyographic characteristics of rat plantaris motor unit types during fatigue in situ. J Physiol (1987) 1.04
Skeletal muscle dysfunction in muscle-specific LKB1 knockout mice. J Appl Physiol (1985) (2010) 1.02
Progressive hyperglycemia across the glucose tolerance continuum in older obese adults is related to skeletal muscle capillarization and nitric oxide bioavailability. J Clin Endocrinol Metab (2011) 1.02
Activation of the Nrf2-ARE pathway in muscle and spinal cord during ALS-like pathology in mice expressing mutant SOD1. Exp Neurol (2007) 1.00
Response of succinate dehydrogenase activity in fibres of rabbit tibialis anterior muscle to chronic nerve stimulation. J Physiol (1983) 1.00
Muscle adaptations and performance enhancements of soccer training for untrained men. Eur J Appl Physiol (2009) 0.99
Functional pools of oxidative and glycolytic fibers in human muscle observed by 31P magnetic resonance spectroscopy during exercise. Proc Natl Acad Sci U S A (1987) 0.98
Abundant expression of myosin heavy-chain IIB RNA in a subset of human masseter muscle fibres. Arch Oral Biol (2001) 0.98
Validation of a simple, rapid, and economical technique for distinguishing type 1 and 2 fibres in fixed and frozen skeletal muscle. J Clin Pathol (2002) 0.97
Department of Neurology, Northwestern University Medical School, Chicago, Illinois. Acta Neuropathol (1977) 0.96
Neuromuscular blockade of slow twitch muscle fibres elevates muscle oxygen uptake and energy turnover during submaximal exercise in humans. J Physiol (2008) 0.95
Effect of exercise training on muscle glucose transporter 4 protein and intramuscular lipid content in elderly men with impaired glucose tolerance. Eur J Appl Physiol (2004) 0.94
Enhancement of microvessel tortuosity in the vastus lateralis muscle of old men in response to endurance training. J Physiol (2003) 0.93
The fibre type composition of thoracic and lumbar paravertebral muscles in man. J Anat (1985) 0.92
The degree of p70 S6k and S6 phosphorylation in human skeletal muscle in response to resistance exercise depends on the training volume. Eur J Appl Physiol (2010) 0.92
Recruitment of fibre types and quadriceps muscle portions during repeated, intense knee-extensor exercise in humans. Pflugers Arch (2004) 0.92
A neuroendocrine basis for the hierarchical control of frog courtship vocalizations. Front Neuroendocrinol (2010) 0.90
Teaching monograph: pathology of skeletal muscle diseases. Am J Pathol (1982) 0.90
Immunolabelling, histochemistry and in situ hybridisation in human skeletal muscle fibres to detect myosin heavy chain expression at the protein and mRNA level. J Anat (2001) 0.89
Relationship between shot put performance and triceps brachii fiber type composition and power production. Eur J Appl Physiol (2003) 0.88
p53 and ATF4 mediate distinct and additive pathways to skeletal muscle atrophy during limb immobilization. Am J Physiol Endocrinol Metab (2014) 0.87
Effects of thyroid hormone on fast- and slow-twitch skeletal muscles in young and old rats. J Physiol (1994) 0.87
Contractile properties of in situ perfused skeletal muscles from rats with congestive heart failure. J Physiol (2002) 0.87
Lethal congenital contracture syndrome: further delineation and genetic aspects. J Med Genet (1994) 0.87
Myosin heavy chain expression and atrophy in rat skeletal muscle during transition from cardiac hypertrophy to heart failure. Int J Exp Pathol (2003) 0.85
Maximum activities of key glycolytic and oxidative enzymes in human muscle from differently trained individuals. J Physiol (1986) 0.85
Glycogen depletion elicited in tenuissimus intrafusal muscle fibres by stimulation of static gamma-axons in the cat. J Physiol (1984) 0.85
The influence of variations in muscle fibre composition on muscle strength and cross-sectional area in untrained males. J Physiol (1984) 0.85
Mitogen-activated protein kinase-activated protein kinases 2 and 3 regulate SERCA2a expression and fiber type composition to modulate skeletal muscle and cardiomyocyte function. Mol Cell Biol (2013) 0.83
Incomplete rematching of nerve and muscle properties in motor units after extensive nerve injuries in cat hindlimb muscle. J Physiol (1998) 0.83
Haematological rather than skeletal muscle adaptations contribute to the increase in peak oxygen uptake induced by moderate endurance training. J Physiol (2015) 0.82
Characterisation of the sarcomeric myosin heavy chain multigene family in the laboratory guinea pig. BMC Mol Biol (2010) 0.82
Reversibility of abdominal wall atrophy and fibrosis after primary or mesh herniorrhaphy. Ann Surg (2013) 0.82
Experimental corticosteroid myopathy. Acta Neuropathol (1981) 0.81
Effects of follicular versus luteal phase-based strength training in young women. Springerplus (2014) 0.81
Analyses of muscle spindles in the soleus of six inbred mouse strains. J Anat (2013) 0.81
COPD elicits remodeling of the diaphragm and vastus lateralis muscles in humans. J Appl Physiol (1985) (2012) 0.81
Effects of chronic stimulation on the metabolic heterogeneity of the fibre population in rabbit tibialis anterior muscle. J Physiol (1984) 0.81
Autophagy signaling in skeletal muscle of infarcted rats. PLoS One (2014) 0.81
Skeletal muscle monocarboxylate transporter content is not different between black and white runners. Eur J Appl Physiol (2008) 0.80
A comprehensive characterisation of the fibre composition and properties of a limb (flexor digitorum superficialis, membri thoraci) and a trunk (psoas major) muscle in cattle. BMC Cell Biol (2008) 0.80
Effects on muscle tissue remodeling and lipid metabolism in muscle tissue from adult patients with polymyositis or dermatomyositis treated with immunosuppressive agents. Arthritis Res Ther (2016) 0.80
Skeletal muscle characterization of Japanese quail line selectively bred for lower body weight as an avian model of delayed muscle growth with hypoplasia. PLoS One (2014) 0.80
"Slow" skeletal muscles across vertebrate species. Cell Biosci (2015) 0.79
Muscle fibre type composition and body composition in hammer throwers. J Sports Sci Med (2010) 0.79
Genetic and genomic analyses of musculoskeletal differences between BEH and BEL strains. Physiol Genomics (2013) 0.79
Contractile properties of muscle fibers from the deep and superficial digital flexors of horses. Am J Physiol Regul Integr Comp Physiol (2010) 0.79
Effect of 28 days of creatine ingestion on muscle metabolism and performance of a simulated cycling road race. J Int Soc Sports Nutr (2010) 0.79
Early changes in muscle atrophy and muscle fiber type conversion after spinal cord transection and peripheral nerve transection in rats. J Neuroeng Rehabil (2013) 0.79
Human cytomegalovirus IE1 promoter/enhancer drives variable gene expression in all fiber types in transgenic mouse skeletal muscle. BMC Genet (2000) 0.79
Molecular cloning and characterization of different expression of MYOZ2 and MYOZ3 in Tianfu goat. PLoS One (2013) 0.79
Slow- and fast-twitch rat hind limb skeletal muscle phenotypes 8 months after spinal cord transection and olfactory ensheathing glia transplantation. J Physiol (2008) 0.79
Effects of Testosterone and Evoked Resistance Exercise after Spinal Cord Injury (TEREX-SCI): study protocol for a randomised controlled trial. BMJ Open (2017) 0.78
Effects of Strength vs. Ballistic-Power Training on Throwing Performance. J Sports Sci Med (2013) 0.78
Nox4 Is Dispensable for Exercise Induced Muscle Fibre Switch. PLoS One (2015) 0.78
Biochemistry of rat single muscle fibres in newly assembled motor units following nerve crush. J Physiol (1984) 0.78
Exercise training induces similar elevations in the activity of oxoglutarate dehydrogenase and peak oxygen uptake in the human quadriceps muscle. Pflugers Arch (2011) 0.78
A single mutation in the acetylcholine receptor δ-subunit causes distinct effects in two types of neuromuscular synapses. J Neurosci (2014) 0.77
Endurance Exercise Enhances the Effect of Strength Training on Muscle Fiber Size and Protein Expression of Akt and mTOR. PLoS One (2016) 0.77
Changes in capillary distribution in rat fast muscles following nerve crush and reinnervation. J Physiol (1985) 0.77
COX Inhibitor Influence on Skeletal Muscle Fiber Size and Metabolic Adaptations to Resistance Exercise in Older Adults. J Gerontol A Biol Sci Med Sci (2016) 0.77
Cycling exercise-induced myofiber transitions in skeletal muscle depend on basal fiber type distribution. Eur J Appl Physiol (2011) 0.77
Caveolin, GLUT4 and insulin receptor protein content in human arm and leg muscles. Eur J Appl Physiol (2009) 0.76
Muscle fiber types: how many and what kind? Arch Neurol (1970) 5.51
Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. N Engl J Med (1989) 3.32
The histographic analysis of human muscle biopsies with regard to fiber types. 1. Adult male and female. Neurology (1969) 2.94
Clinical trial in Duchenne dystrophy. I. The design of the protocol. Muscle Nerve (1981) 2.06
Clinical investigation in Duchenne dystrophy: 2. Determination of the "power" of therapeutic trials based on the natural history. Muscle Nerve (1983) 1.99
The histographic analysis of human muscle biopsies with regard to fiber types. 4. Children's biopsies. Neurology (1969) 1.93
Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group. Arch Neurol (1991) 1.78
Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months) Neurology (1993) 1.75
The histographic analysis of human muscle biopsies with regard to fiber types. 2. Diseases of the upper and lower motor neuron. Neurology (1969) 1.64
Some comments on the histochemical characterization of muscle adenosine triphosphatase. J Histochem Cytochem (1969) 1.63
Enzyme patterns in single human muscle fibers. J Biol Chem (1978) 1.59
Histochemical studies of denervated or tenotomized cat muscle: illustrating difficulties in relating experimental animal conditions to human neuromuscular diseases. Ann N Y Acad Sci (1966) 1.48
Long-term benefit from prednisone therapy in Duchenne muscular dystrophy. Neurology (1991) 1.40
The histographic analysis of human muscle biopsies with regard to fiber types. 3. Myotonias, myasthenia gravis, and hypokalemic periodic paralysis. Neurology (1969) 1.29
Reducing body myopathy. Neurology (1972) 1.26
Increased serum creatine kinase after exercise: a sex-linked phenomenon. Neurology (1979) 1.21
Chronic stimulation of mammalian muscle: changes in enzymes of six metabolic pathways. Am J Physiol (1986) 1.21
Enzyme levels in individual rat muscle fibers. Am J Physiol (1980) 1.17
A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophy. Arch Neurol (1991) 1.16
Clinical investigation of Duchenne muscular dystrophy. Interesting results in a trial of prednisone. Arch Neurol (1987) 1.14
Muscle pathology in rheumatoid arthritis, polymyalgia rheumatica, and polymyositis: a histochemical study. Arch Pathol (1972) 1.12
Activity, creatine kinase, and myoglobin in Duchenne muscular dystrophy: a clue to etiology? Neurology (1985) 1.06
Myoadenylate deaminase deficiency. Muscle Nerve (1980) 1.06
Histochemistry of human extraocular muscle. Arch Ophthalmol (1978) 1.05
Metabolite changes in individual rat muscle fibers during stimulation. Am J Physiol (1982) 1.05
Trophic functions of the neuron. II. Denervation and regulation of muscle. The use and abuse of muscle histochemistry. Ann N Y Acad Sci (1974) 1.02
Clinical investigation of Duchenne muscular dystrophy. A methodology for therapeutic trials based on natural history controls. Arch Neurol (1987) 1.02
Studies in myoclonus epilepsy. (Lafora body form). IV. Skeletal muscle abnormalities. Arch Neurol (1974) 1.01
Exercise hyperventilation in patients with McArdle's disease. J Appl Physiol Respir Environ Exerc Physiol (1982) 1.01
The histologic diagnosis of neuromuscular diseases: a review of 79 biopsies. Arch Phys Med Rehabil (1966) 1.01
The prolonged exercise test. Neurology (1979) 1.01
Comparison of muscle fiber typing by quantitative enzyme assays and by myosin ATPase staining. J Histochem Cytochem (1984) 1.00
Clinical investigation in Duchenne dystrophy: V. Use of creatine kinase and pyruvate kinase in carrier detection. Muscle Nerve (1985) 0.98
The behavior of four fiber types in developing and reinnervated muscle. Arch Neurol (1971) 0.96
Contractile, biochemical, and histochemical properties of thyrotoxic rat soleus muscle. Am J Physiol (1980) 0.95
Depressed ventilatory response in oculocraniosomatic neuromuscular disease. Neurology (1976) 0.95
Appearance in slow muscule sarcolemma of specializations characteristic of fast muscle after reinnervation by a fast muscle nerve. Exp Neurol (1978) 0.94
Facioscapulohumeral dystrophy associated with hearing loss and Coats syndrome. Ann Neurol (1982) 0.91
Acetazolamide-responsive myotonia congenita. Neurology (1987) 0.90
Mononuclear cell analysis of muscle biopsies in prednisone- and azathioprine-treated Duchenne muscular dystrophy. Neurology (1993) 0.89
Muscle pathology of myotonia congenita. J Neurol Sci (1976) 0.88
Biochemical and physiologic consequences of carnitine palmityltransferase deficiency. Muscle Nerve (1979) 0.87
Genetic abnormalities in Duchenne and Becker dystrophies: clinical correlations. Neurology (1989) 0.87
Myophosphorylase deficiency: two different molecular etiologies. Neurology (1976) 0.86
The natural history of Duchenne muscular dystrophy: a caveat for therapeutic trials. Trans Am Neurol Assoc (1981) 0.86
Clinical investigation in Duchenne dystrophy. VI. Double-blind controlled trial of nifedipine. Muscle Nerve (1987) 0.85
Effect of Duchenne muscular dystrophy on enzymes of energy metabolism in individual muscle fibers. Metabolism (1987) 0.85
Hypoxanthine and Mcardle disease: a clue to metabolic stress in the working forearm. Muscle Nerve (1983) 0.84
Vascular insufficiency in McArdle's disease. Neurology (1983) 0.84
Genetic heterogeneity in Duchenne dystrophy. Ann Neurol (1987) 0.84
Congenital hypotonia revisited. Muscle Nerve (1980) 0.84
Controlled trial of thyrotropin releasing hormone in amyotrophic lateral sclerosis. Neurology (1986) 0.82
Randomized controlled trial of testosterone in myotonic dystrophy. Neurology (1989) 0.82
Bicycle ergometry and gas exchange measurements in neuromuscular diseases. Arch Neurol (1979) 0.81
McArdle's disease with myoadenylate deaminase deficiency: observations in a combined enzyme deficiency. Neurology (1987) 0.81
Riboflavin-responsive lipid myopathy and carnitine deficiency. Neurology (1981) 0.81
Carnitine "deficiency": lack of response to carnitine therapy. Neurology (1980) 0.81
Rostrocaudal variation of fiber type composition in rat intercostal muscles. Histochemistry (1991) 0.80
Effects of calcium channel antagonists on the release of prostaglandin E2 from metabolically stressed muscle. Biochem Pharmacol (1994) 0.80
Palmitate oxidation in human muscle: comparison to CPT and carnitine. Muscle Nerve (1982) 0.80
Endurance exercise training in a patient with central core disease. Neurology (1980) 0.80
Three human myosin ATPase systems and their importance in muscle pathology. Neurology (1970) 0.79
Carnitine intake and excretion in neuromuscular diseases. Am J Clin Nutr (1981) 0.79
Two dissimilar brothers with Becker's dystrophy have an identical genetic defect. Neurology (1989) 0.79
Glutathione depletion during experimental damage to rat skeletal muscle and its relevance to Duchenne muscular dystrophy. Clin Sci (Lond) (1991) 0.78
Exercising muscle does not produce hypoxanthine in adenylate deaminase deficiency. Neurology (1983) 0.78
Clinical investigation in Duchenne muscular dystrophy: IV. Double-blind controlled trial of leucine. Muscle Nerve (1984) 0.78
Clinical investigation in Duchenne muscular dystrophy: penicillamine and vitamin E. Muscle Nerve (1988) 0.78
Adenylate deaminase deficiency in a hypotonic infant. J Pediatr (1980) 0.78
Myoencephalopathy: cerebral hypomyelination revealed by CT scan of the head in a muscle disease. Trans Am Neurol Assoc (1979) 0.78
ATPase stain in muscle histochemistry. Muscle Nerve (1992) 0.78
Forearm exercise increases plasma hypoxanthine. J Neurol Neurosurg Psychiatry (1982) 0.77
Increased long chain acyl CoA in Duchenne muscular dystrophy. Neurology (1983) 0.77
Carrier assessment for mothers and sisters of isolated Duchenne dystrophy cases: the importance of serum enzyme determinations. Neurology (1987) 0.77
'Dystrophic' lipid myopathy in two sisters. Arch Neurol (1986) 0.77
Use of serum creatine kinase, pyruvate kinase, and genetic linkage for carrier detection in Duchenne and Becker dystrophy. Neurology (1987) 0.76
Randomized, double-blind trial of mazindol in Duchenne dystrophy. Muscle Nerve (1990) 0.76
Clinical examination of patients with neuromuscular disease. Adv Neurol (1977) 0.76
Creatine kinase and prostaglandin E2 release from isolated Duchenne muscle. Neurology (1991) 0.76
Neurotrophic factors decrease the release of creatine kinase and prostaglandin E2 from metabolically stressed muscle. Neuromuscul Disord (1998) 0.76